6533b82afe1ef96bd128cbce

RESEARCH PRODUCT

Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation

Carlos Arterio SorgiRoberto NicoleteLúcia Helena FaccioliLaura PiquerasEdson Garcia SoaresCristina RiusMaría José SanzMaría José SanzPeter J. Jose

subject

lcsh:Immunologic diseases. Allergymedicine.medical_specialtyLeukotriene B4ImmunologyChemokinesisLeukocyte RollingBiologyPharmacologyNitric OxideLeukotriene B4Nitric oxideMicechemistry.chemical_compoundCell MovementInternal medicineCell AdhesionLeukocytesmedicineAnimalsHumansLeukocyte RollingPPAR alphaLungChemokine CCL2NitritesLeukotrieneMonocyteEndothelial CellsChemotaxisMicrospheresEndocrinologymedicine.anatomical_structurechemistryMacrophages Peritoneallipids (amino acids peptides and proteins)Cell activationlcsh:RC581-607Research Article

description

AbstractBackgroundLeukotriene B4(LTB4) is a potent inflammatory mediator that also stimulates the immune response. In addition, it promotes polymorphonuclear leukocyte phagocytosis, chemotaxis, chemokinesis and modulates cytokines release. Regarding chemical instability of the leukotriene molecule, in the present study we assessed the immunomodulatory activities conferred by LTB4released from microspheres (MS). A previous oil-in-water emulsion solvent extraction-evaporation method was chosen to prepare LTB4-loaded MS.ResultsIn the mice cremasteric microcirculation, intraescrotal injection of 0.1 ml of LTB4-loaded MS provoked significant increases in leukocyte rolling flux, adhesion and emigration besides significant decreases in the leukocyte rolling velocity. LTB4-loaded MS also increase peroxisome proliferator-activated receptor-α (PPARα) expression by murine peritoneal macrophages and stimulate them to generate nitrite levels. Monocyte chemoattractant protein-1 (MCP-1) and nitric oxide (NO) productions were also increased when human umbilical vein and artery endothelial cells (HUVECs and HUAECs, respectively) were stimulated with LTB4-loaded MS.ConclusionLTB4-loaded MS preserve the biological activity of the encapsulated mediator indicating their use as a new strategy to modulate cell activation, especially in the innate immune response.

10.1186/1471-2172-9-36http://www.biomedcentral.com/1471-2172/9/36